Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atara Biotherapeutics (ATRA) Inventory (2022 - 2024)

Atara Biotherapeutics (ATRA) has disclosed Inventory for 3 consecutive years, with $10.7 million as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Inventory rose 9.78% year-over-year to $10.7 million, compared with a TTM value of $10.7 million through Dec 2024, up 9.78%, and an annual FY2024 reading of $10.7 million, up 9.78% over the prior year.
  • Inventory was $10.7 million for Q4 2024 at Atara Biotherapeutics, down from $14.0 million in the prior quarter.
  • Across five years, Inventory topped out at $18.7 million in Q2 2024 and bottomed at $1.6 million in Q4 2022.
  • Average Inventory over 3 years is $11.2 million, with a median of $10.7 million recorded in 2024.
  • The sharpest move saw Inventory skyrocketed 511.98% in 2023, then grew 9.78% in 2024.
  • Year by year, Inventory stood at $1.6 million in 2022, then surged by 511.98% to $9.7 million in 2023, then rose by 9.78% to $10.7 million in 2024.
  • Business Quant data shows Inventory for ATRA at $10.7 million in Q4 2024, $14.0 million in Q3 2024, and $18.7 million in Q2 2024.